Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1992 Nov;82(11):1500–1505. doi: 10.2105/ajph.82.11.1500

The reporting of HIV/AIDS deaths in women.

J W Buehler 1, D L Hanson 1, S Y Chu 1
PMCID: PMC1694604  PMID: 1443300

Abstract

OBJECTIVE. This study was undertaken to assess the completeness of vital statistics and case reports of acquired immunodeficiency syndrome (AIDS) in measuring human immunodeficiency virus (HIV)-related mortality in women 15 through 44 years of age. METHODS. We used vital records to determine the number of deaths attributed to HIV infection and excess deaths due to causes that have increased in tandem with the HIV epidemic. RESULTS. In 1988, among women 15 through 44 years of age, there were 1365 deaths with HIV infection listed as the underlying cause, 202 deaths with HIV infection listed as an associated cause, and 149 excess deaths due to conditions highly associated with HIV infection (subtotal = 1716). In addition, there were 780 excess deaths due to causes that may be related to HIV infection or illicit drug use (maximum estimate of HIV-related deaths = 2496). Of the deaths that occurred in 1988, 1532 were reported through AIDS surveillance (1668 deaths when adjusted for reporting delays). CONCLUSIONS. Underlying-cause-of-death vital records and AIDS surveillance identified 55% to 80% and 67% to 97%, respectively, of HIV-related deaths in women 15 through 44 years of age in 1988. The wide ranges of these estimates reflect the potential role of both HIV infection and drug use in contributing to excess mortality.

Full text

PDF
1500

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alonso K., Solomons E. T., Dawson J. B. Bacteremic death: sequel of persistent rhinitis precipitated by intranasal cocaine abuse. South Med J. 1986 Aug;79(8):1049–1049. doi: 10.1097/00007611-198608000-00039. [DOI] [PubMed] [Google Scholar]
  2. Berkowitz K., LaSala A. Risk factors associated with the increasing prevalence of pneumonia during pregnancy. Am J Obstet Gynecol. 1990 Sep;163(3):981–985. doi: 10.1016/0002-9378(90)91109-p. [DOI] [PubMed] [Google Scholar]
  3. Buehler J. W., Devine O. J., Berkelman R. L., Chevarley F. M. Impact of the human immunodeficiency virus epidemic on mortality trends in young men, United States. Am J Public Health. 1990 Sep;80(9):1080–1086. doi: 10.2105/ajph.80.9.1080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chu S. Y., Buehler J. W., Berkelman R. L. Impact of the human immunodeficiency virus epidemic on mortality in women of reproductive age, United States. JAMA. 1990 Jul 11;264(2):225–229. [PubMed] [Google Scholar]
  5. Haverkos H. W., Lange W. R. From the Alcohol, Drug Abuse, and Mental Health Administration. Serious infections other than human immunodeficiency virus among intravenous drug abusers. J Infect Dis. 1990 May;161(5):894–902. doi: 10.1093/infdis/161.5.894. [DOI] [PubMed] [Google Scholar]
  6. Horsburgh C. R., Jr, Anderson J. R., Boyko E. J. Increased incidence of infections in intravenous drug users. Infect Control Hosp Epidemiol. 1989 May;10(5):211–215. doi: 10.1086/646004. [DOI] [PubMed] [Google Scholar]
  7. Johnson J. C., Burnett A. F., Willet G. D., Young M. A., Doniger J. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol. 1992 Mar;79(3):321–327. doi: 10.1097/00006250-199203000-00001. [DOI] [PubMed] [Google Scholar]
  8. Kristal A. R. The impact of the acquired immunodeficiency syndrome on patterns of premature death in New York City. JAMA. 1986 May 2;255(17):2306–2310. [PubMed] [Google Scholar]
  9. O'Donnell A. E., Pappas L. S. Pulmonary complications of intravenous drug abuse. Experience at an inner-city hospital. Chest. 1988 Aug;94(2):251–253. doi: 10.1378/chest.94.2.251. [DOI] [PubMed] [Google Scholar]
  10. Perucci C. A., Davoli M., Rapiti E., Abeni D. D., Forastiere F. Mortality of intravenous drug users in Rome: a cohort study. Am J Public Health. 1991 Oct;81(10):1307–1310. doi: 10.2105/ajph.81.10.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pollock D. A., Holmgreen P., Lui K. J., Kirk M. L. Discrepancies in the reported frequency of cocaine-related deaths, United States, 1983 through 1988. JAMA. 1991 Oct 23;266(16):2233–2237. [PubMed] [Google Scholar]
  12. Rabkin C. S., Blattner W. A. HIV infection and cancers other than non-Hodgkin lymphoma and Kaposi's sarcoma. Cancer Surv. 1991;10:151–160. [PubMed] [Google Scholar]
  13. Schäfer A., Friedmann W., Mielke M., Schwartländer B., Koch M. A. The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol. 1991 Feb;164(2):593–599. doi: 10.1016/s0002-9378(11)80029-3. [DOI] [PubMed] [Google Scholar]
  14. Selik R. M., Buehler J. W., Karon J. M., Chamberland M. E., Berkelman R. L. Impact of the 1987 revision of the case definition of acquired immune deficiency syndrome in the United States. J Acquir Immune Defic Syndr. 1990;3(1):73–82. [PubMed] [Google Scholar]
  15. Selwyn P. A., Feingold A. R., Hartel D., Schoenbaum E. E., Alderman M. H., Klein R. S., Friedland G. H. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS. 1988 Aug;2(4):267–272. doi: 10.1097/00002030-198808000-00005. [DOI] [PubMed] [Google Scholar]
  16. Selwyn P. A., Hartel D., Wasserman W., Drucker E. Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am J Public Health. 1989 Oct;79(10):1358–1362. doi: 10.2105/ajph.79.10.1358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Selwyn P. A. Injection drug use, mortality, and the AIDS epidemic. Am J Public Health. 1991 Oct;81(10):1247–1249. doi: 10.2105/ajph.81.10.1247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Silverman H. S., Smith A. L. Staphylococcal sepsis precipitated by cocaine sniffing. N Engl J Med. 1985 Jun 27;312(26):1706–1706. doi: 10.1056/nejm198506273122611. [DOI] [PubMed] [Google Scholar]
  19. Stoneburner R. L., Des Jarlais D. C., Benezra D., Gorelkin L., Sotheran J. L., Friedman S. R., Schultz S., Marmor M., Mildvan D., Maslansky R. A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City. Science. 1988 Nov 11;242(4880):916–919. doi: 10.1126/science.3187532. [DOI] [PubMed] [Google Scholar]
  20. Vermund S. H., Kelley K. F., Klein R. S., Feingold A. R., Schreiber K., Munk G., Burk R. D. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol. 1991 Aug;165(2):392–400. doi: 10.1016/0002-9378(91)90101-v. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES